Steven Cohen Legend Biotech Corp Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $4.75 Million - $6.54 Million	-109,149 Reduced 35.84%	195,371 $9.52 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $12 Million - $17.4 Million	304,520 New	304,520 $13.5 Million
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $4.04 Million - $6.05 Million	-105,900 Reduced 49.74%	107,000 $4.37 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $7.14 Million - $11.7 Million	212,900 New	212,900 $11.7 Million
Q2 2021 Aug 16, 2021	SELL	$25.8 - $41.09 $42.3 Million - $67.4 Million	-1,639,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $38.6 Million - $53.1 Million	1,639,200 New	1,639,200 $47.6 Million

233

86.1M

260K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.19B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.